Mr. Prasad is the Promoter of Granules and has over two decades of experience in managing pharmaceutical manufacturing units. In 1984, he set up Triton Laboratories, which has become one of the world’s largest manufacturers of Paracetamol. Mr. Prasad pioneered and popularized the concept of Pharmaceutical Formulations Intermediates (PFIs) as a cost efficient product for global formulations manufacturers.

Dr. Arumugam has been with Granules since 2007. His notable accomplishments include launching an operational excellence program throughout the organization. He previously worked at Eastman Chemical Co. Kingsport in various roles. Dr. Arumugam received his B. Tech in Chemical Engineering from The Indian Institute of Technology - Chennai, MBA from the Fuqua School of Business at Duke University and PhD. from Purdue University.

Mr. Mathur has served as CFO of Granules for over five years. As CFO, he formed the joint-venture with Hubei Biocause and was also responsible for implementing an ERP system. Prior to Granules, Mr. Mathur worked at several companies where his responsibilities included launching an IPO and raising funding for manufacturing plants. Mr. Mathur is a Chartered Accountant; he has received his MBA from Osmania University and is currently enrolled in the EMBA program at the Indian School of Business.

Mr. Harsha Chigurupati holds a Bachelor's Degree in Business Management from Boston University, with a concentration in Entrepreneurship and B2B Marketing. He worked for a semester in 2004 with Gillette and undertook a project related to global supply chain optimization which had brought a savings of 13% in storage and transportation costs. After a brief period at Granules USA Inc, Mr. Chigurupati served at Granules India Limited as Chief Marketing Officer through July 2010. Mr. Chigurupati was instrumental in Granules’ vertically-integrated business strategy. During his tenure, Granules gained nearly 100 customers, including several major multi-national companies.